Myoflex Cream Side Effects

Generic Name: trolamine salicylate topical

Note: This page contains side effects data for the generic drug trolamine salicylate topical. It is possible that some of the dosage forms included below may not apply to the brand name Myoflex Cream.

It is possible that some side effects of Myoflex Cream may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.

Applies to trolamine salicylate topical: topical cream, topical lotion, topical pad

General

In general, trolamine salicylate topical (the active ingredient contained in Myoflex Cream) has been safe to use. If applied over a large area, salicylate type side effects (e.g., tinnitus, nausea, and/or vomiting) could potentially occur.

More about Myoflex Cream (trolamine salicylate topical)

Consumer resources

Related treatment guides

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web2)